| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,8153 | -0,22 % | €722,55M | €1,20M | |
| €40,0048 | +0,00 % | €722,12M | €111,31K | |
| €17,2446 | +1,42 % | €721,07M | €136,16 | |
EVC Entravision Communication | €7,4029 | -0,12 % | €720,21M | €178,39 | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €23,8072 | +0,05 % | €718,82M | €10,34 | |
| €22,2646 | -0,06 % | €717,21M | €233,54 | |
AMPH Amphastar Pharmaceuticals, Inc. | €15,6072 | -0,06 % | €716,28M | €95,65 | |
MATW Matthews International Corp | €21,9199 | -0,02 % | €713,66M | €4,309 | |
TBPH Theravance Biopharma, Inc. | €13,7112 | -0,06 % | €713,51M | €0,8618 | |
MPB Mid Penn Bancorp, Inc. | €27,1639 | +0,03 % | €713,15M | €126,06K | |
KRO Kronos Worldwide, Inc. | €5,9723 | -1,98 % | €712,90M | €127,05K | |
ADAM Adamas Trust, Inc. Common Stock | €7,5666 | -0,11 % | €712,46M | €121,51 | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €18,8648 | +0,00 % | €710,89M | €18,47K | |
ROOT Root, Inc. Class A Common Stock | €45,0980 | -0,08 % | €710,05M | €177,53 | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,5721 | +3,03 % | €709,53M | €1,723 | |
